Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Adalimumab »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Acyclovir < Adalimumab < Adaptive Immunity  Facettes :

List of bibliographic references indexed by Adalimumab

Number of relevant bibliographic references: 136.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B14 (2019) Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Mariana Lima Nour [Brésil] ; Valdenir Freire Peixoto Filho [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Marco Felipe Castro Da Silva [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]Long-term breastfeeding influences disease activity in a low-income juvenile idiopathic arthritis cohort.
000C01 (2019) Martijn J H. Doeleman ; Erik M. Van Maarseveen [Pays-Bas] ; Joost F. SwartImmunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis.
000C84 (2019) Sara Touhami [France] ; Eléonore Diwo [France] ; Pascal Sève [France] ; Salim Trad [France] ; Philip Bielefeld [France] ; Damien Sène [France] ; Sebastien Abad [France] ; Antoine Brézin [France] ; Pierre Quartier [France] ; Isabelle Koné Paut [France] ; Michel Weber [France] ; Christophe Chiquet [France] ; Marie-Hélène Errera [France] ; Jérémie Sellam [France] ; Patrice Cacoub [France] ; Gilles Kaplanski [France] ; Laurent Kodjikian [France] ; Bahram Bodaghi [France] ; David Saadoun [France]Expert opinion on the use of biological therapy in non-infectious uveitis.
000C94 (2019) Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Marcela Gondim Aguiar [Brésil] ; João Pedro Emrich Accioly [Brésil] ; Carolina Noronha Lechiu [Brésil] ; Luiza Helena Acácio Costa [Brésil] ; Carlos Nobre Rabelo Júnior [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
000D49 (2019) Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis]Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
000D56 (2019) Masakazu Kondo [Japon] ; Hisakata Yamada [Japon]Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
000E36 (2019) Stephanie Finzel [Allemagne] ; Sebastian Kraus [Allemagne] ; Camille Pinto Figueiredo [Allemagne] ; Adrian Regensburger [Allemagne] ; Roland Kocijan [Allemagne] ; Juergen Rech [Allemagne] ; Georg Schett [Allemagne]Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
000F30 (2019) Akshay S. Thomas [États-Unis]Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
001019 (2019) Théo Willeman [France] ; Jean-François Jourdil [France] ; Elodie Gautier-Veyret [France] ; Bruno Bonaz [France] ; Françoise Stanke-Labesque [France]A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
001085 (2018) A. Pierrot [France] ; C. Combe [France] ; M. Lepelley [France] ; M. Brucker [France] ; E. Constant [France][Berger's disease associated to an adalimumab-treated rheumatoid arthritis].
001087 (2018) Fusao Komada ; Yuko Nakayama ; Kohji Takara[Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents].
001094 (2018) Indu Javeri [États-Unis] ; Kaliappanadar Nellaiappan [États-Unis] ; Charles Mcnemar [États-Unis] ; Kirill Yakovlevsky [États-Unis] ; Amina Soukrati [États-Unis] ; Phanindra Velisetty [États-Unis] ; Bijay Misra [États-Unis]Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.
001100 (2018) Wen-Chan Chiu [Taïwan] ; Han-Ming Lai [Taïwan] ; Chi-Hua Ko [Taïwan] ; Jia-Feng Chen [Taïwan] ; Chung-Yuan Hsu [Taïwan] ; Ying-Chou Chen [Taïwan]Ultrasound is more reliable than inflammatory parameters to evaluate disease activity in patients with RA receiving tocilizumab therapy.
001179 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.
001204 (2018) Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
001265 (2018) Lluís Puig [Espagne]Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
001370 (2018) Ying-Chou Chen [Taïwan] ; Wen-Chan Chiu [Taïwan] ; Fu-Mei Su [Taïwan] ; Jia-Feng Chen [Taïwan]Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
001420 (2018) Alison O'Mahony [États-Unis] ; Markus R. John [Suisse] ; Hannah Cho [États-Unis] ; Misato Hashizume [Suisse] ; Ernest H. Choy [Royaume-Uni]Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate.
001423 (2018) Shingo Nakayamada [Japon] ; Satoshi Kubo [Japon] ; Maiko Yoshikawa [Japon] ; Yusuke Miyazaki [Japon] ; Naoki Yunoue [Japon] ; Shigeru Iwata [Japon] ; Ippei Miyagawa [Japon] ; Shintaro Hirata [Japon] ; Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
001446 (2018) Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
001488 (2018) Yi-Ming Chen [Taïwan] ; Chun-Yu Chang [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Kuo-Tung Tang [Taïwan] ; Meng-Chun Yang [Taïwan] ; Joung-Liang Lan [Taïwan] ; Der-Yuan Chen [Taïwan]Association between autophagy and inflammation in patients with rheumatoid arthritis receiving biologic therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Adalimumab" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Adalimumab" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Adalimumab
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021